| Filed On | Filing |
|---|---|
| 29 Oct 2026 |
8-K: Results of Operations and Financial Condition
NEW YORK, NY, October 29, 2026 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announc... |
| 15 Oct 2026 |
8-K: Entry into a Material Definitive Agreement
Certain identified information has been redacted from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. [***] indicates that information has been redacted. |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
NEW YORK, NY, August 6, 2026 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced... |
| 29 Jun 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
NEW YORK, NY, June 29, 2026 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction,announced today t... |
| 22 May 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On May 22, 2026, the Company held the Annual Meeting of Shareholders. The Company's shareholders voted on three proposals at the Annual Meeting of Shareholders and the voting results for each of these proposals are set forth below. |
| 06 May 2026 |
8-K: Results of Operations and Financial Condition
NEW YORK, NY, May 6, 2026 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced fi... |
| 30 Apr 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
On April 30, 2026 (the “Closing Date”), Establishment Labs Holdings Inc. (the “Company”) entered into an Amended Credit Agreement and Guaranty (the “Credit Agreement”) together with certain of its subsidiaries party thereto as guarantors... |
| 24 Feb 2026 |
8-K: Results of Operations and Financial Condition
NEW YORK, NY, February 24, 2026 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announ... |
| 14 Jan 2026 |
8-K: Regulation FD Disclosure
On January 14, 2026, Establishment Labs (the "Company") presented at the J.P. Morgan Healthcare Conference. |
| 12 Jan 2026 |
8-K: Results of Operations and Financial Condition
NEW YORK, NY, January 12, 2026 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announc... |
| 05 Nov 2025 |
8-K: Results of Operations and Financial Condition
NEW YORK, NY, November 5, 2025 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announc... |
| 03 Oct 2025 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
This Fourth Amendment to the Credit Agreement and Guaranty (this “Amendment”) is made as of September 29, 2025, by and among ESTABLISHMENT LABS HOLDINGS INC., a BVI business company limited by shares incorporated under the BVI Business C... |
| 07 Aug 2025 |
8-K: Results of Operations and Financial Condition
NEW YORK, NY, August 7, 2025 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced... |
| 12 Jun 2025 |
8-K: Regulation FD Disclosure
Agenda Topic Presenter/Moderator Welcome; Logistics; Agenda Raj Denhoy Corporate Overview Peter Caldini Motiva® USA Business Updates Jeff Ehrhardt US Breast Aesthetic - Panel Ben Newcott Breast Reconstruction Opportunity in the USA Jeff ... |
| 27 May 2025 |
8-K: Submission of Matters to a Vote of Security Holders
On May 23, 2025, the Company held the Annual Meeting of Shareholders. The Company's shareholders voted on three proposals at the Annual Meeting of Shareholders and the voting results for each of these proposals are set forth below. |
| 22 May 2025 |
8-K: Changes in Registrant's Certifying Accountant; Other Events
We have read the statements made by Establishment Labs Holdings, Inc. under Item 4.01 of its Form 8-K dated May 20, 2025. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree wi... |
| 07 May 2025 |
8-K: Results of Operations and Financial Condition
NEW YORK, NY, May 7, 2025 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced fi... |
| 07 May 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
NEW YORK, NY, May 7, 2025 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction announced today the... |
| 10 Apr 2025 |
8-K: Results of Operations and Financial Condition
NEW YORK, NY, April 10, 2025 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, provided prelim... |
| 26 Feb 2025 |
8-K: Results of Operations and Financial Condition
NEW YORK, NY, February 26, 2025 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announ... |
Loading...